Chan, Hok Yee
Choi, John
Jackson, Christina
Lim, Michael
Article History
Received: 14 January 2020
Accepted: 1 April 2020
First Online: 21 February 2021
Compliance with ethical standards
:
: Michael Lim (Funding from Arbor Pharmaceuticals, Accuray, BMS, Novartis; Consultant: BMS, Merck, SQZ Biotechnologies, Tocagen, VBI; Patents: Combining Focused Radiation and Immunotherapy, Combining Local Chemotherapy and Immunotherapy).